WTW

Willis Towers Watson Public
D

WTW

Arincen67/100B

If you had invested in Willis Towers Watson Public ago, it would be worth $3,235 today, against $4,128 in SPY and $6,186 in QQQ.

ArincenArincen ScoreBeta

67/100

Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.

Profitability6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Cash10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Valuation8

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Growth6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Financial strength2

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Shareholders8

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Figures to FY2025; the price as of today.

Willis Towers Watson Public key facts

Style
Value stock · 6.8/10Growth 4.8 · Value 6.8 · Dividend 4.3
Day range
328.06 – 333.84
52-week range
240.61 – 351.51
Market capitalization
30.33B USD
P/E
19.98
PEG ratio
1.07
EPS
16.46
Div Yield
1.17%
EPS growth forecast (FY2026)
+15.5%
Volume
13,132
Beta
0.44
Sector
Financial Services
Industry
Insurance - Brokers
CEO
Carl Aaron Hess
Employees
48K
Website
wtwco.com
IPO date
12 Jun 2001

Willis Towers Watson Public earnings

Next earnings · Q4 FY2026
EPS estimate
9.18 USD
Revenue estimate
3.12B USD
Last quarter · Q3 FY2026
EPS3.63Beat +1.1%Revenue2.46BBeat +0.2%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20274.34——+19.56%2.59B——+5.20%
Q2 FY20273.83——+14.23%2.58B——+4.56%
Q1 FY20274.26——+14.62%2.54B——+5.44%
Q4 FY20269.18——+13.05%3.12B——+6.43%
Q3 FY20263.593.63+1.11%+18.24%2.45B2.46B+0.22%+7.52%
Q2 FY20263.113.35+7.72%+17.13%2.42B2.47B+2.05%+9.07%
Q1 FY20263.663.72+1.64%+18.85%2.41B2.41B-0.06%+8.50%
Q4 FY20257.968.12+2.01%-0.12%2.85B2.94B+2.91%-3.26%
Q3 FY20253.053.07+0.66%+4.78%2.27B2.29B+0.59%-0.04%
Q2 FY20252.632.86+8.75%+12.16%2.23B2.26B+1.45%-0.22%

Willis Towers Watson Public analyst forecast

12-month price target
358.11 USD
+8.89%

Analysts' 1-year price targets range from 310.00 to 405.00, with an average of 358.11.

Past year
1-year forecast
Strong sellStrong buy
Buy
15 ratings
Strong buy
0
Buy
10
Hold
5
Sell
0
Strong sell
0

12-month price target

Highest target405.00
Average target358.11
Lowest target310.00
Current price328.88

Willis Towers Watson Public valuation

Price to earnings ratio (TTM)
19.98
Forward P/E (FY2026)
16.58
Price to sales (TTM)
2.95
Price to book
3.91
EV / EBITDA (TTM)
12.81

Capital structure

Market capitalization
30.33B USD
+
Total debt
7.10B USD
−
Cash and short-term investments
1.95B USD
=
Enterprise value
35.48B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)12.09————
FY2027 (est.)14.3612.09———
FY2026 (est.)16.5814.36———
Now (TTM)19.9814.652.953.9112.81
FY202520.1116.573.324.0413.45
FY2024-326.2918.463.224.0243.73
FY202324.0014.452.672.6614.78
FY202227.1817.363.092.7315.55
FY202115.8117.743.382.298.84

Willis Towers Watson Public against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Brown & Brown, Arthur J. Gallagher &, Marsh & McLennan Companies, Ryan Specialty Holdings, and CorVel, the US Insurance - Brokers companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median20.0
    6.5217.3
  • Gross marginBelow its median42.1%
    41.6%44.6%
    Against its peers: 5 of 6Peers' median 49.1%
  • Operating marginAbove its median23.0%
    6.3%24.5%
    Against its peers: 3 of 6Peers' median 20.5%
  • Net marginAbove its median16.5%
    -1.0%46.9%
    Against its peers: 2 of 6Peers' median 11.5%
  • Return on equityAbove its median20.1%
    -1.2%31.8%
    Against its peers: 3 of 6Peers' median 9.8%
  • Free cash flow marginAbove its median15.9%
    6.9%20.7%
    Against its peers: 4 of 6Peers' median 18.5%
  • Revenue growthLowest in 5 years-2.2%
    -2.2%7.0%
    Against its peers: 6 of 6Peers' median 20.7%
  • Debt to EBITDABelow its median2.58×
    1.54×7.21×
    Against its peers: 2 of 6Peers' median 3.82×
  • Current ratioAbove its median1.20
    1.061.26
    Against its peers: 3 of 6Peers' median 1.10

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Willis Towers Watson Public growth and profitability

Revenue (TTM)
10.27B USD
Net income (TTM)
1.56B USD
Gross margin
38.52%
Operating margin
22.56%
Net margin
15.22%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY20259.71B-2.24%1.61B—42.06%23.01%16.53%2.68B+225.03%
FY20249.93B+4.71%-98.00M-109.29%44.59%6.31%-0.99%823.00M-59.24%
FY20239.48B+6.96%1.06B+4.56%43.65%14.39%11.13%2.02B-0.69%
FY20228.87B-1.47%1.01B-76.10%42.87%13.29%11.38%2.03B-42.78%
FY20219.00B+4.45%4.22B+323.90%41.62%24.47%46.92%3.55B+75.46%

Willis Towers Watson Public revenue breakdown

By product

FY2025
Health, Wealth and Career: 55.1%Risk and Broking: 44.9%55.1%Health, Wealth and Career44.9%Risk and Broking
SegmentRevenueShare of revenueChange on the year
Health, Wealth and Career5.33B55.1%-8.9%
Risk and Broking4.35B44.9%+7.3%

By region

FY2025
International: 49.6%United States: 23.4%Rest Of World: 15.5%United Kingdom: 10.7%Ireland: 0.7%49.6%International23.4%United States15.5%Rest Of World10.7%United Kingdom
RegionRevenueShare of revenueChange on the year
International9.57B49.6%—
United States4.50B23.4%-12.2%
Rest Of World3.00B15.5%+6.5%
United Kingdom2.07B10.7%+11.1%
Ireland143.00M0.7%+9.2%

How Willis Towers Watson Public makes its money

Health, Wealth and Career5.33B 54.9%
Risk and Broking4.35B 44.8%
Revenue9.71B 100.0%
Cost of revenue5.63B 57.9%
Gross profit4.08B 42.1%
Other operating expenses1.85B 19.0%
Operating income2.23B 23.0%
Tax318.00M 3.3%
Other expense311.00M 3.2%
Net income1.61B 16.5%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Willis Towers Watson Public dividends

Annual dividend
3.84 USD
Dividend yield (indicated)
1.17%
Payout ratio
23.09%
Years of dividend growth
10
Frequency
Quarterly
Last payment
0.96 USD
Last ex-dividend date
30 Sept 2026
Last payment date
15 Oct 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share3.643.483.343.262.932.692.552.332.071.44

Willis Towers Watson Public financial health

Cash and short-term investments
1.95B USD
Total debt
7.10B USD
Net cash
-5.15B USD
Free cash flow (TTM)
1.74B USD
Current ratio
1.10
Debt to equity
0.91
Piotroski score
6 / 9
Altman Z-score
1.45

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20253.13B6.91B1.55B
FY20241.89B5.93B1.27B
FY20231.42B5.94B1.10B
FY20221.26B5.48B608.00M
FY20214.69B5.49B1.86B

Willis Towers Watson Public ownership

Institutions
97.62%
Institutional holders
711 (-28)
Free float
99.56%

Who owns the shares

Institutions 97.6% Others 2.4%
As of 30 Jun 2026

Shares free to trade

Free float 91.81M shares ·99.6% Closely held 406.34K shares ·0.4%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 202600918.591.92K
Q3 202601951.60730.00
Q2 20262034.00K60.17K
Q1 202621109.03K5.17K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY202598.00M99.00M-2.94%
FY2024102.00M102.00M-3.77%
FY2023105.00M106.00M-5.36%
FY2022112.00M112.00M-13.18%
FY2021128.00M129.00M-0.77%

Source: Financial Modeling Prep

Related Instruments

Title: Willis Towers Watson Public Limited

Sector: Financial Services
Industry: Insurance - Brokers
Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas:Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.

Common questions about Willis Towers Watson Public stock

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.